Aldehyde Dehydrogenase 1B1 (ALDH1B1): Molecular Cloning and Characterization of A

Total Page:16

File Type:pdf, Size:1020Kb

Aldehyde Dehydrogenase 1B1 (ALDH1B1): Molecular Cloning and Characterization of A DMD Fast Forward. Published on July 8, 2010 as DOI: 10.1124/dmd.110.034678 DMDThis Fast article Forward. has not been Published copyedited and on formatted. July 8, The2010 final as version doi:10.1124/dmd.110.034678 may differ from this version. DMD #34678 Aldehyde dehydrogenase 1B1 (ALDH1B1): Molecular cloning and characterization of a novel mitochondrial acetaldehyde metabolizing enzyme Downloaded from Dimitrios Stagos †, Ying Chen †, Chad Brocker, Elizabeth Donald, Brian C. Jackson, David J. Orlicky, David C. Thompson, and Vasilis Vasiliou dmd.aspetjournals.org Department of Pharmaceutical Sciences (D.S., Y.C., C.B., E.D., B.J., V.V.), Department of at ASPET Journals on September 24, 2021 Pathology (D.O.), and Department of Clinical Pharmacy (D.T.), University of Colorado Denver, Aurora, CO 80045 1 Copyright 2010 by the American Society for Pharmacology and Experimental Therapeutics. DMD Fast Forward. Published on July 8, 2010 as DOI: 10.1124/dmd.110.034678 This article has not been copyedited and formatted. The final version may differ from this version. DMD #34678 RUNNING TITLE PAGE Running title: Initial characterization of human ALDH1B1 Corresponding author: Vasilis Vasiliou, PhD Department of Pharmaceutical Sciences University of Colorado Denver, Aurora, CO 80045, USA Downloaded from Phone: (303) 724-3520; fax: (303) 724-2666 e-mail: [email protected]. dmd.aspetjournals.org Number of text pages: 24 (including references) Number of tables: 1 Number of figures: 5 at ASPET Journals on September 24, 2021 Number of references: 40 Word count: Abstract: 243 Introduction: 701 (excluding citations) Di scussion: 1271 Abbreviations: ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenases; RA, retinoic acid; 4-HNE, 4-Hydroxynonenal; M DA, Malondiadehyde; ORF, open reading frame; FPLC, fast protein liquid chromatography; Q- PCR, q uantitative r eal-time P CR; I HC, immunohistochemistry; IHF, immunoflurescence; DAPI, 4 ,6-diamidino-2-phenylindole; M OI, m ultiplicity o f infection; p-NPA, p-nitrophenyl acetate; GTN, glyceryl trinitrate; 2 DMD Fast Forward. Published on July 8, 2010 as DOI: 10.1124/dmd.110.034678 This article has not been copyedited and formatted. The final version may differ from this version. DMD #34678 ABSTRACT Ethanol-induced damage is largely attributed to its toxic metabolite, acetaldehyde. Clearance of acetaldehyde is achieved by its oxidation, primarily catalyzed by the mitochondrial class II aldehyde dehydrogenase (ALDH2). ALDH1B1 is another mitochondrial ALDH that shares 75% peptide sequence h omology w ith A LDH2. R ecent p opulation studies in C aucasians suggest a r ole f or ALDH1B1 in e thanol m etabolism. Ho wever, to da te, no f ormal Downloaded from documentation of t he biochemical pr operties of A LDH1B1 ha s been f orthcoming. I n th is current study, we cloned and expressed human recombinant ALDH1B1 in Sf9 insect cells. The resultant enzyme was purified by affinity chromatography to homogeneity. The kinetic dmd.aspetjournals.org properties o f pur ified h uman A LDH1B1 w ere a ssessed using a w ide range o f a ldehyde substrates. Human ALDH1B1 had an exclusive preference for NAD+ as the cofactor and was catalytically active towards short- and medium-chain aliphatic aldehydes, aromatic aldehydes at ASPET Journals on September 24, 2021 and the products of li pid pe roxidation, 4-hydroxy-nonenal ( 4-HNE) a nd malondialdehyde (MDA). M ost im portantly, hum an ALDH1B1 e xhibited an a pparent Km o f 55 μM f or acetaldehyde, making i t t he second low Km A LDH for m etabolism of t his su bstrate. The dehydrogenase activity of ALDH1B1 was sensitive to disulfiram inhibition, a feature a lso shared with ALDH2. The tissue distribution of ALDH1B1 in C57BL/6J mice and human was examined by Q- PCR, Western bl otting a nd im munohistochemical a nalysis. H ighest expression oc curred in th e li ver, f ollowed b y t he intestinal t ract, i mplicating a p otential physiological role of ALDH1B1 in these tissues. The current study is the first report on the expression, purification and biochemical characterization of human ALDH1B1 protein. 3 DMD Fast Forward. Published on July 8, 2010 as DOI: 10.1124/dmd.110.034678 This article has not been copyedited and formatted. The final version may differ from this version. DMD #34678 INTRODUCTION Excessive alcohol consumption leads to a variety of psychological and pathological consequences. Ch ronic alcohol i ntake i s often associated with damage t o mu ltiple o rgans, manifesting as hepatitis, liver cirrhosis, brain damage, and immune dysfunction. Many of the toxic effects of ethanol are attributable to ethanol metabolism. Ethanol is metabolized in the liver to acetaldehyde predominantly by class I alcohol dehydrogenase isoenzymes (ADH1A, Downloaded from ADH1B a nd ADH1C ) loc ated i n th e c ytosol o f h epatocytes. Ald ehyde d ehydrogenases (ALDHs) then oxidize acetaldehyde to acetate and water (Crabb et al., 2004). Acetaldehyde, the intermediate metabolite of ethanol, is toxic and its accumulation contributes significantly dmd.aspetjournals.org to ethanol-induced tissue damage (Eriksson, 2001; Meier and Seitz, 2008). The t oxicity o f acetaldehyde is caused by it covalently binding biological macromolecules, such as proteins and n ucleic acids, and f orming a dducts that impair t heir functions (N iemela, 2 007). at ASPET Journals on September 24, 2021 Acetaldehyde also induces lipid peroxidation, increased collagen synthesis and glutathione depletion (Esterbauer et al., 1991). Moreover, protein adducts with acetaldehyde and products of li pid peroxidation tr igger autoimmune responses th at a re associated wi th a lcoholic liver disease (Stewart et al ., 2 004; V iitala et al ., 2 000). Met abolism and el imination o f acetaldehyde is, therefore, of great importance for cellular d efense against ethanol-induced toxicities. Among the nineteen known human ALDHs, mitochondrial ALDH2 a nd, to a le sser extent, cytosolic ALDH1A1 have been shown to play a major role in acetaldehyde oxidation and elimination (Vasiliou and Pappa, 2000). Both enzymes, homotetramers with a 55 KDa subunit, exhibit low Km constants for acetaldehyde, viz. 3.2 and 180 μM for human ALDH2 and A LDH1A1, re spectively ( Klyosov et al ., 1 996). T he i mportance o f ALDH2 i n the clearance o f ac etaldehyde is exemplified i n humans car rying t he ALDH2*2 al lele, w hich 4 DMD Fast Forward. Published on July 8, 2010 as DOI: 10.1124/dmd.110.034678 This article has not been copyedited and formatted. The final version may differ from this version. DMD #34678 encodes a functional mutation (Glu487Lys) of ALDH2 and results in poor binding affinity to cofactor NAD+ and > 90% loss of enzyme activity (Larson et al., 2005; Yoshida et al., 1984). When compared t o w ild-type individuals, b lood acet aldehyde levels climb 2 0- an d 6-fold higher in homozygous a nd he terozygous in dividuals carrying t his p olymorphism, respectively, for equivalent levels of alcohol consumption (Crabb et al., 1989). This causes the “al cohol fl ushing” s yndrome c haracterized by the r eddening o f t he face, n eck, and in some cases the entire body due to dilation of capillaries (Eriksson, 2001). Similar elevations Downloaded from in acet aldehyde h ave been o bserved i n the Aldh2-null mice ( Yu e t al., 2009). The s econd enzyme involved in acetaldehyde metabolism is ALDH1A1. In addition to its crucial role in retinoic acid (RA) biosynthesis (Duester, 2000), cytosolic ALDH1A1 has been shown to be dmd.aspetjournals.org important in acetaldehyde metabolism and alcohol preference in rodent studies (Bond et al., 1991; B ond a nd S ingh, 1990; L ittle a nd P etersen, 1 983). H uman studies a lso r eport t he association of ALDH1A1 variants with enzyme deficiency in Caucasian “flushers” (Eriksson, at ASPET Journals on September 24, 2021 2001). Nevertheless, the contribution of ALDH1A1 to acetaldehyde metabolism appears to be less important in humans than rodent, likely because rodent ALDH1A1 has a much lower Km for acetaldehyde (15 μM) (Klyosov et al., 1996). ALDH1B1, p reviously known a s A LDHX a nd AL DH5, represents a nother mitochondrial AL DH i soenzyme. T he hum an ALDH1B1 ge ne loc ated on c hromosome 9 spans a 5,957 bp region and is the only known ALDH gene with an intronless coding region (Hsu and Chang, 1991). ALDH1B1 gene is composed of two exons and one intron and has only one known transcript variant (Black et al., 2009). ALDH1B1 enzyme, like ALDH2 and ALDH1A1, is predicted to be a homotetramer; the subunit contains 517 amino acids with a N-terminal 1 9-residue mi tochondrial l ead s ignal. Ba sed o n p eptide sequence al ignment, human A LDH1B1 shares 65% a nd 75 % ho mology with human A LDH1A1 a nd ALDH2, respectively. Northern blot analysis in human tissues have shown high levels of ALDH1B1 5 DMD Fast Forward. Published on July 8, 2010 as DOI: 10.1124/dmd.110.034678 This article has not been copyedited and formatted. The final version may differ from this version. DMD #34678 mRNA in the liver and testis and relatively low levels in other tissues (Hsu and Chang, 1991; Stewart et al., 1996). ALDH1B1 has also been found to be expressed abundantly in mouse and bovine corneas (Stagos et al., 2010), where cells are constantly exposed to UV-induced lipid p eroxidation. To date, li ttle is kn own r egarding th e biochemical properties a nd physiological roles of A LDH1B1. A s tudy u sing crude ly sate f rom HuH7 he patoma c ells reported that mitochondrial ALDH1B1 contributed to the oxidation of short chain aldehydes including acet aldehyde and propionaldehyde, i mplicating a ro le f or A LDH1B1 i n ethanol Downloaded from metabolism (Stewart et al., 1995).
Recommended publications
  • (ALDH1A3) for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
    Author Manuscript Published OnlineFirst on June 6, 2014; DOI: 10.1158/1078-0432.CCR-13-3292 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Essential role of aldehyde dehydrogenase 1A3 (ALDH1A3) for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway Chunli Shao1,2, James P. Sullivan3, Luc Girard1,2, Alexander Augustyn1,2, Paul Yenerall1,2, Jaime Rodriguez4, Hui Liu4, Carmen Behrens4, Jerry W. Shay5, Ignacio I. Wistuba4, John D. Minna 1,2,6,7 1Hamon Center for Therapeutic Oncology Research, 2Simmons Comprehensive Cancer Center, 3Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, 02114, 4Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77054, 5Department of Cell Biology, 6Department of Pharmacology, 7Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA. Running Title: ALDH1A3 in non-small cell lung cancer stem cells Keywords: Lung cancer, cancer stem cells, ALDH1A3, STAT3, Stattic Financial Support This project was supported by CPRIT, NCI SPORE P50CA70907, UTSW Cancer Center Support Grant 5P30-CA142543, and the Gillson-Longenbaugh Foundation. Address Correspondence: John D. Minna, M.D. 6000 Harry Hines Blvd Dallas, TX 75390-8593 Hamon Center for Therapeutic Oncology Research UT Southwestern Medical Center Phone: 214-648-4900; Fax: 214-648-4940 [email protected] Disclosure of Potential Conflict of Interest The authors indicate no potential conflicts of interest. Word count: 4583 Total number of figures and tables: 6 figures Downloaded from clincancerres.aacrjournals.org on September 28, 2021. © 2014 American Association for Cancer Research.
    [Show full text]
  • Identify Distinct Prognostic Impact of ALDH1 Family Members by TCGA Database in Acute Myeloid Leukemia
    Open Access Annals of Hematology & Oncology Research Article Identify Distinct Prognostic Impact of ALDH1 Family Members by TCGA Database in Acute Myeloid Leukemia Yi H, Deng R, Fan F, Sun H, He G, Lai S and Su Y* Department of Hematology, General Hospital of Chengdu Abstract Military Region, China Background: Acute myeloid leukemia is a heterogeneous disease. Identify *Corresponding author: Su Y, Department of the prognostic biomarker is important to guide stratification and therapeutic Hematology, General Hospital of Chengdu Military strategies. Region, Chengdu, 610083, China Method: We detected the expression level and the prognostic impact of Received: November 25, 2017; Accepted: January 18, each ALDH1 family members in AML by The Cancer Genome Atlas (TCGA) 2018; Published: February 06, 2018 database. Results: Upon 168 patients whose expression level of ALDH1 family members were available. We found that the level of ALDH1A1correlated to the prognosis of AML by the National Comprehensive Cancer Network (NCCN) stratification but not in other ALDH1 members. Moreover, we got survival data from 160 AML patients in TCGA database. We found that high ALDH1A1 expression correlated to poor Overall Survival (OS), mostly in Fms-like Tyrosine Kinase-3 (FLT3) mutated group. HighALDH1A2 expression significantly correlated to poor OS in FLT3 wild type population but not in FLT3 mutated group. High ALDH1A3 expression significantly correlated to poor OS in FLT3 mutated group but not in FLT3 wild type group. There was no relationship between the OS of AML with the level of ALDH1B1, ALDH1L1 and ALDH1L2. Conclusion: The prognostic impacts were different in each ALDH1 family members, which needs further investigation.
    [Show full text]
  • Update on the Aldehyde Dehydrogenase Gene (ALDH) Superfamily Brian Jackson,1 Chad Brocker,1 David C
    GENOME UPDATE Update on the aldehyde dehydrogenase gene (ALDH) superfamily Brian Jackson,1 Chad Brocker,1 David C. Thompson,2 William Black,1 Konstandinos Vasiliou,1 Daniel W. Nebert3 and Vasilis Vasiliou1* 1Molecular Toxicology and Environmental Health Sciences Program, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA 2Department of Clinical Pharmacy, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA 3Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267, USA *Correspondence to: Tel: þ1 303 724 3520; Fax: þ1 303 724 7266; E-mail: [email protected] Date received (in revised form): 23rd March 2011 Abstract Members of the aldehyde dehydrogenase gene (ALDH) superfamily play an important role in the enzymic detoxifi- cation of endogenous and exogenous aldehydes and in the formation of molecules that are important in cellular processes, like retinoic acid, betaine and gamma-aminobutyric acid. ALDHs exhibit additional, non-enzymic func- tions, including the capacity to bind to some hormones and other small molecules and to diminish the effects of ultraviolet irradiation in the cornea. Mutations in ALDH genes leading to defective aldehyde metabolism are the molecular basis of several diseases, including gamma-hydroxybutyric aciduria, pyridoxine-dependent seizures, Sjo¨gren–Larsson syndrome and type II hyperprolinaemia. Interestingly, several ALDH enzymes appear to be markers for normal and cancer stem cells. The superfamily is evolutionarily ancient and is represented within Archaea, Eubacteria and Eukarya taxa. Recent improvements in DNA and protein sequencing have led to the identification of many new ALDH family members.
    [Show full text]
  • Plenary and Platform Abstracts
    American Society of Human Genetics 68th Annual Meeting PLENARY AND PLATFORM ABSTRACTS Abstract #'s Tuesday, October 16, 5:30-6:50 pm: 4. Featured Plenary Abstract Session I Hall C #1-#4 Wednesday, October 17, 9:00-10:00 am, Concurrent Platform Session A: 6. Variant Insights from Large Population Datasets Ballroom 20A #5-#8 7. GWAS in Combined Cancer Phenotypes Ballroom 20BC #9-#12 8. Genome-wide Epigenomics and Non-coding Variants Ballroom 20D #13-#16 9. Clonal Mosaicism in Cancer, Alzheimer's Disease, and Healthy Room 6A #17-#20 Tissue 10. Genetics of Behavioral Traits and Diseases Room 6B #21-#24 11. New Frontiers in Computational Genomics Room 6C #25-#28 12. Bone and Muscle: Identifying Causal Genes Room 6D #29-#32 13. Precision Medicine Initiatives: Outcomes and Lessons Learned Room 6E #33-#36 14. Environmental Exposures in Human Traits Room 6F #37-#40 Wednesday, October 17, 4:15-5:45 pm, Concurrent Platform Session B: 24. Variant Interpretation Practices and Resources Ballroom 20A #41-#46 25. Integrated Variant Analysis in Cancer Genomics Ballroom 20BC #47-#52 26. Gene Discovery and Functional Models of Neurological Disorders Ballroom 20D #53-#58 27. Whole Exome and Whole Genome Associations Room 6A #59-#64 28. Sequencing-based Diagnostics for Newborns and Infants Room 6B #65-#70 29. Omics Studies in Alzheimer's Disease Room 6C #71-#76 30. Cardiac, Valvular, and Vascular Disorders Room 6D #77-#82 31. Natural Selection and Human Phenotypes Room 6E #83-#88 32. Genetics of Cardiometabolic Traits Room 6F #89-#94 Wednesday, October 17, 6:00-7:00 pm, Concurrent Platform Session C: 33.
    [Show full text]
  • Genotype-Stratified GWAS Meta-Analysis Reveals Novel Loci Associated with Alcohol Consumption Yuriko N
    medRxiv preprint doi: https://doi.org/10.1101/2021.06.02.21258094; this version posted June 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Genotype-stratified GWAS meta-analysis reveals novel loci associated with alcohol consumption Yuriko N. Koyanagi1#, Masahiro Nakatochi2#*, Hidemi Ito1,3, Yumiko Kasugai4,5, Akira Narita6, Takahisa Kawaguchi7, Hiroaki Ikezaki8,9, Asahi Hishida10, Megumi Hara11, Toshiro Takezaki12, Teruhide Koyama13, Haruo Mikami14, Sadao Suzuki15, Sakurako Katsuura-Kamano16, Kiyonori Kuriki17, Yasuyuki Nakamura18, Kenji Takeuchi10, Atsushi Hozawa19, Kengo Kinoshita6, Yoichi Sutoh20, Kozo Tanno21,22, Atsushi Shimizu20,23, Isao Oze4, Yukino Kawakatsu4, Yukari Taniyama1, Issei Imoto24, Yasuharu Tabara7, Meiko Takahashi7, Kazuya Setoh7, Shiori Suzuki25, Atsushi Goto25,26, Ryoko Katagiri25, Taiki Yamaji25, Norie Sawada25, Shoichiro Tsugane25,27, Kenji Wakai10, Masayuki Yamamoto6, Makoto Sasaki28,29, Fumihiko Matsuda7, Motoki Iwasaki25, Paul Brennan30, Keitaro Matsuo4,5* 1. Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. 2. Public Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan. 3. Department of Descriptive Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. 4. Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. 5. Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. 6. Department of Integrative Genomics, Tohoku Medical MegaBank Organization, Tohoku University, Sendai, Japan. 7. Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    [Show full text]
  • Genetic Variants in ALDH1B1 and Alcohol Dependence Risk in a British and Irish Population: a Bioinformatic and Genetic Study
    RESEARCH ARTICLE Genetic variants in ALDH1B1 and alcohol dependence risk in a British and Irish population: A bioinformatic and genetic study Michael J. Way1,2, M. Adam Ali1,2, Andrew McQuillin1, Marsha Y. Morgan2* 1 Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, United Kingdom, 2 UCL Institute for Liver & Digestive Health, Department of Medicine, Royal Free Campus, University College London, London, United Kingdom a1111111111 * [email protected] a1111111111 a1111111111 a1111111111 Abstract a1111111111 Alcohol is metabolized in the liver via the enzymes alcohol dehydrogenase (ADH) and alde- hyde dehydrogenase (ALDH). Polymorphisms in the genes encoding these enzymes, which are common in East Asian populations, can alter enzyme kinetics and hence the risk of alco- OPEN ACCESS hol dependence and its sequelae. One of the most important genetic variants, in this regards, is the single nucleotide polymorphism (SNP) rs671 in ALDH2, the gene encoding Citation: Way MJ, Ali MA, McQuillin A, Morgan MY (2017) Genetic variants in ALDH1B1 and alcohol the primary acetaldehyde metabolizing enzyme ALDH2. However, the protective allele of dependence risk in a British and Irish population: A rs671 is absent in most Europeans although ALDH1B1, which shares significant sequence bioinformatic and genetic study. PLoS ONE 12(6): homology with ALDH2, contains several, potentially functional, missense SNPs that do e0177009. https://doi.org/10.1371/journal. pone.0177009 occur in European populations. The aims of this study were: (i) to use bioinformatic tech- niques to characterize the possible effects of selected variants in ALDH1B1 on protein struc- Editor: Yong-Gang Yao, Kunming Institute of Zoology, Chinese Academy of Sciences, CHINA ture and function; and, (ii) to genotype three missense and one stop-gain, protein-altering, non-synonymous SNPs in 1478 alcohol dependent cases and 1254 controls of matched Received: October 12, 2016 British and Irish ancestry.
    [Show full text]
  • Insights Into Aldehyde Dehydrogenase Enzymes: a Structural Perspective
    REVIEW published: 14 May 2021 doi: 10.3389/fmolb.2021.659550 Insights into Aldehyde Dehydrogenase Enzymes: A Structural Perspective Kim Shortall, Ahmed Djeghader, Edmond Magner and Tewfik Soulimane* Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland Aldehyde dehydrogenases engage in many cellular functions, however their dysfunction resulting in accumulation of their substrates can be cytotoxic. ALDHs are responsible for the NAD(P)-dependent oxidation of aldehydes to carboxylic acids, participating in detoxification, biosynthesis, antioxidant and regulatory functions. Severe diseases, including alcohol intolerance, cancer, cardiovascular and neurological diseases, were linked to dysfunctional ALDH enzymes, relating back to key enzyme structure. An in-depth understanding of the ALDH structure-function relationship and mechanism of action is key to the understanding of associated diseases. Principal structural features 1) cofactor binding domain, 2) active site and 3) oligomerization mechanism proved critical in maintaining ALDH normal activity. Emerging research based on the combination of structural, functional and biophysical studies of bacterial and eukaryotic ALDHs contributed to the appreciation of diversity within the superfamily. Herewith, we Edited by: discuss these studies and provide our interpretation for a global understanding of Ashley M Buckle, ALDH structure and its purpose–including correct function and role in disease. Our Monash University, Australia analysis provides a synopsis
    [Show full text]
  • Isoenzymes in Gastric Cancer
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 18 Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer Jia-Xin Shen1,*, Jing Liu2,3,*, Guan-Wu Li4, Yi-Teng Huang5, Hua-Tao Wu1 1Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, PR China 2Chang Jiang Scholar’s Laboratory, Shantou University Medical College, Shantou, PR China 3Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou, PR China 4Open Laboratory for Tumor Molecular Biology/Department of Biochemistry, The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, PR China 5Health Care Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, PR China *These authors contributed equally to this work Correspondence to: Hua-Tao Wu, email: [email protected] Keywords: ALDH1, gastric cancer, prognosis, KM plotter, hazard ratio (HR) Received: October 27, 2015 Accepted: March 10, 2016 Published: March 23, 2016 ABSTRACT Aldehyde dehydrogenase 1 (ALDH1) consists of a family of intracellular enzymes, highly expressed in stem cells populations of leukemia and some solid tumors. Up to now, 6 isoforms of ALDH1 have been reported. However, the expression patterns and the identity of ALDH1 isoenzymes contributing to ALDH1 activity, as well as the prognostic values of ALDH1 isoenzymes in cancers all remain to be elucidated. Here, we studied the expressions of ALDH1 transcripts in gastric cancer (GC) compared with the normal controls using the ONCOMINE database. Through the Kaplan-Meier plotter database, which contains updated gene expression data and survival information of 876 GC patients, we also investigated the prognostic values of ALDH1 isoenzymes in GC patients.
    [Show full text]
  • Phylogeny and Evolution of Aldehyde Dehydrogenase-Homologous Folate Enzymes
    Chemico-Biological Interactions 191 (2011) 122–128 Contents lists available at ScienceDirect Chemico-Biological Interactions journal homepage: www.elsevier.com/locate/chembioint Phylogeny and evolution of aldehyde dehydrogenase-homologous folate enzymes Kyle C. Strickland a, Roger S. Holmes b, Natalia V. Oleinik a, Natalia I. Krupenko a, Sergey A. Krupenko a,∗ a Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425 USA b School of Biomolecular and Physical Sciences, Griffith University, Nathan 4111 Brisbane, Queensland, Australia article info abstract Article history: Folate coenzymes function as one-carbon group carriers in intracellular metabolic pathways. Folate- Available online 6 January 2011 dependent reactions are compartmentalized within the cell and are catalyzed by two distinct groups of enzymes, cytosolic and mitochondrial. Some folate enzymes are present in both compartments Keywords: and are likely the products of gene duplications. A well-characterized cytosolic folate enzyme, FDH Folate metabolism (10-formyltetrahydro-folate dehydrogenase, ALDH1L1), contains a domain with significant sequence Mitochondria similarity to aldehyde dehydrogenases. This domain enables FDH to catalyze the NADP+-dependent 10-Formyltetrahydrofolate dehydrogenase conversion of short-chain aldehydes to corresponding acids in vitro. The aldehyde dehydrogenase-like Aldehyde dehydrogenase Domain structure reaction is the final step in the overall FDH mechanism, by which a tetrahydrofolate-bound formyl group + Evolution is oxidized to CO2 in an NADP -dependent fashion. We have recently cloned and characterized another folate enzyme containing an ALDH domain, a mitochondrial FDH. Here the biological roles of the two enzymes, a comparison of the respective genes, and some potential evolutionary implications are dis- cussed.
    [Show full text]
  • Aldehyde Dehydrogenase, Liver Disease and Cancer Wenjun Wang1, Chunguang Wang2, Hongxin Xu1, Yanhang Gao1
    Int. J. Biol. Sci. 2020, Vol. 16 921 Ivyspring International Publisher International Journal of Biological Sciences 2020; 16(6): 921-934. doi: 10.7150/ijbs.42300 Review Aldehyde Dehydrogenase, Liver Disease and Cancer Wenjun Wang1, Chunguang Wang2, Hongxin Xu1, Yanhang Gao1 1. Department of Hepatology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin, 130021, China. 2. Department of Thoracic & Cardiovascular Surgery, Second Clinical College, Jilin University, Changchun, 130041, China. Corresponding author: Yanhang Gao, MD., PhD., Department of Hepatology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin, 130021, China. Email: [email protected]. Tel: +86 15804303019; +86 431 81875121; +86 431 81875106; Fax number: 0431-81875106. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2019.11.20; Accepted: 2020.01.03; Published: 2020.01.22 Abstract Acetaldehyde dehydrogenase 2 (ALDH2) is the key enzyme responsible for metabolism of the alcohol metabolite acetaldehyde in the liver. In addition to conversion of the acetaldehyde molecule, ALDH is also involved in other cellular functions. Recently, many studies have investigated the involvement of ALDH expression in viral hepatitis, alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), liver fibrosis, and liver cancer. Notably, ALDH2 expression has been linked with liver cancer risk, as well as pathogenesis and prognosis, and has emerged as a promising therapeutic target. Of note, approximately 8% of the world’s population, and approximately 30-40% of the population in East Asia carry an inactive ALDH2 gene.
    [Show full text]
  • Metabolic Network-Based Stratification of Hepatocellular Carcinoma Reveals Three Distinct Tumor Subtypes
    Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes Gholamreza Bidkhoria,b,1, Rui Benfeitasa,1, Martina Klevstigc,d, Cheng Zhanga, Jens Nielsene, Mathias Uhlena, Jan Borenc,d, and Adil Mardinoglua,b,e,2 aScience for Life Laboratory, KTH Royal Institute of Technology, SE-17121 Stockholm, Sweden; bCentre for Host-Microbiome Interactions, Dental Institute, King’s College London, SE1 9RT London, United Kingdom; cDepartment of Molecular and Clinical Medicine, University of Gothenburg, SE-41345 Gothenburg, Sweden; dThe Wallenberg Laboratory, Sahlgrenska University Hospital, SE-41345 Gothenburg, Sweden; and eDepartment of Biology and Biological Engineering, Chalmers University of Technology, SE-41296 Gothenburg, Sweden Edited by Sang Yup Lee, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea, and approved November 1, 2018 (received for review April 27, 2018) Hepatocellular carcinoma (HCC) is one of the most frequent forms of of markers associated with recurrence and poor prognosis (13–15). liver cancer, and effective treatment methods are limited due to Moreover, genome-scale metabolic models (GEMs), collections tumor heterogeneity. There is a great need for comprehensive of biochemical reactions, and associated enzymes and transporters approaches to stratify HCC patients, gain biological insights into have been successfully used to characterize the metabolism of subtypes, and ultimately identify effective therapeutic targets. We HCC, as well as identify drug targets for HCC patients (11, 16–18). stratified HCC patients and characterized each subtype using tran- For instance, HCC tumors have been stratified based on the uti- scriptomics data, genome-scale metabolic networks and network lization of acetate (11). Analysis of HCC metabolism has also led topology/controllability analysis.
    [Show full text]
  • A Pathway-Centric Approach to Rare Variant Association Analysis
    European Journal of Human Genetics (2017) 25, 123–129 Official journal of The European Society of Human Genetics www.nature.com/ejhg ARTICLE A pathway-centric approach to rare variant association analysis Tom G Richardson1, Nicholas J Timpson1, Colin Campbell2 and Tom R Gaunt*,1 Current endeavours in rare variant analysis are typically underpowered when investigating association signals from individual genes. We undertook an approach to rare variant analysis which utilises biological pathway information to analyse functionally relevant genes together. Conventional filtering approaches for rare variant analysis are based on variant consequence and are therefore confined to coding regions of the genome. Therefore, we undertook a novel approach to this process by obtaining functional annotations from the Combined Annotation Dependent Depletion (CADD) tool, which allowed potentially deleterious variants from intronic regions of genes to be incorporated into analyses. This work was undertaken using whole-genome sequencing data from the UK10K project. Rare variants from the KEGG pathway for arginine and proline metabolism were collectively associated with systolic blood pressure (P = 3.32x10 − 5) based on analyses using the optimal sequence kernel association test. Variants along this pathway also showed evidence of replication using imputed data from the Avon Longitudinal Study of Parents and Children cohort (P = 0.02). Subsequent analyses found that the strength of evidence diminished when analysing genes in this pathway individually, suggesting
    [Show full text]